The Effect of Proton Pump Inhibitors on Early Implant Failure A Retrospective Cohort Study

被引:3
|
作者
Masri, Daya [1 ]
Retzkin, Noga [2 ]
de Souza, Sergio Luis Scombatti [3 ]
Slutzkey, Gil S. [2 ]
Tagger-Green, Nirit [2 ]
Naishlos, Sarit [4 ]
Chaushu, Liat [2 ]
机构
[1] Tel Aviv Univ, Sch Dent, Dept Oral & Maxillofacial Surg, IL-6997801 Tel Aviv, Israel
[2] Tel Aviv Univ, Sch Dent, Dept Periodontol & Implant Dent, IL-6997801 Tel Aviv, Israel
[3] Univ Sao Paulo, Fac Odontol Ribeirao Preto, Dept CTBMF & Periodontia, BR-14040904 Sao Paulo, Brazil
[4] Tel Aviv Univ, Sch Dent, Dept Pediat Dent, IL-6997801 Tel Aviv, Israel
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 02期
关键词
proton pump inhibitors; early implant failure; dental implant; DENTAL IMPLANTS; OSSEOINTEGRATION; RISK;
D O I
10.3390/medicina59020402
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Maintenance of a firm and long-term stable osseointegration is the primary goal of implant dentistry. Time is used to define implant failure characteristics. Early implant failure (EIF) occurs up to one year after loading. Recent studies indicated an association between proton pump inhibitors (PPI) therapy and failure of osseointegration. The present study assessed whether the use of PPIs is a risk factor to EIF. Materials and methods: A retrospective cohort study including 687 patients and 2971 dental implants. The study group (PPIs users) comprised 17.3% (119) individuals and 18.7% (555) implants. The remaining cohort (82.7% (568) individuals and 81.3% (2416) implants) served as control. The information was taken from the patients' files. The following information was collected: age, gender, physical status, systemic diseases, HbA1C values before and after implant-supported prosthesis delivery in cases of diabetes mellitus, smoking, implant location, number of implants per individual, bone augmentation, implant brand, length and width, and EIF. EIF was defined as implant removal within a period of up to 12 months from loading. Results: EIF in PPIs vs. non-PPIs users was 19.3% vs. 14.3% (p = 0.16) at patient level and 5.4% vs. 3.5% at implant level (p = 0.03). Univariate analysis yielded factors significantly associated with PPIs use, including older age, physical status of the American Society of Anesthesiology (ASA) 3, hypertension, hyperlipidemia, diabetes mellitus, osteoporosis, cardiovascular accident (CVA), location (anterior mandible), shorter and narrower implants, and higher number of implants per individual. Multivariate analysis yielded statistically significant OR of 1.91; p = 0.01 for EIF following PPIs use and 2.3; p < 0.001 for location in anterior mandible. Conclusions: Patients and their healthcare providers are advised to carefully consider the potential risks of taking PPIs prior to dental implant surgery. Further research is needed to confirm these risks and elucidate systemic and local factors that may be involved in such outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Proton Pump Inhibitors and the Risk of Osseointegrated Dental Implant Failure: A Cohort Study
    Wu, Xixi
    Al-Abedalla, Khadijeh
    Abi-Nader, Samer
    Daniel, Nach G.
    Nicolau, Belinda
    Tamimi, Faleh
    CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, 2017, 19 (02) : 222 - 232
  • [2] The Effect of Anticoagulants on Early Implant Failure: A Retrospective Cohort Study
    Chaushu, Liat
    Perez, Noa
    Botticelli, Daniele
    Xavier, Samuel Porfirio
    Kolerman, Roni
    Masri, Daya
    JOURNAL OF FUNCTIONAL BIOMATERIALS, 2023, 14 (04)
  • [3] Proton Pump Inhibitors Therapy and Anemia: A Retrospective Cohort Study
    Grover, Madhusudan
    Sarzynski, Erin
    Puttarajappa, Chethan
    Xie, Yan
    Laird-Fick, Heather
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (02) : 185 - 186
  • [4] Gastrointestinal tuberculosis is not associated with proton pump inhibitors: A retrospective cohort study
    Hong, Kyoung Sup
    Kang, Seung Joo
    Choi, Jong Kyoung
    Kim, Ju Han
    Seo, Heewon
    Lee, Suehyun
    Jung, Jae-Woo
    Kang, Hye-Ryun
    Cho, Sang-Heon
    Kim, Joo Sung
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (02) : 258 - 264
  • [5] PROTON PUMP INHIBITORS AND RISK OF GASTRIC CANCER: A RETROSPECTIVE COHORT STUDY
    Choi, J.
    Hong, K. S.
    Kang, S. J.
    Kim, J. S.
    HELICOBACTER, 2013, 18 : 111 - 111
  • [6] Gastrointestinal tuberculosis is not associated with proton pump inhibitors:A retrospective cohort study
    Kyoung Sup Hong
    Seung Joo Kang
    Jong Kyoung Choi
    Ju Han Kim
    Heewon Seo
    Suehyun Lee
    Jae-Woo Jung
    Hye-Ryun Kang
    Sang-Heon Cho
    Joo Sung Kim
    World Journal of Gastroenterology, 2013, (02) : 258 - 264
  • [7] Effect of Implant Maintenance on Incidence of Peri-implantitis and Early Implant Failure: Retrospective Cohort Study
    Deeb, Janina Golob
    Ha, Michael
    Carrico, Caroline K.
    Waldrop, Thomas
    Lee, Pandora K.
    JOURNAL OF ORAL IMPLANTOLOGY, 2024, 50 (04) : 328 - 334
  • [8] Are proton pump inhibitors associated with implant failure and peri-implantitis?
    Rogoszinski, Tamar
    Dazen, Cody
    Rekawek, Peter
    Coburn, John F.
    Carr, Brian R.
    Boggess, William
    Chuang, Sung-Kiang
    Lee, Kevin C.
    Panchal, Neeraj
    Ford, Brian P.
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2022, 133 (01): : 15 - 20
  • [9] Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study
    Hart, Emily
    Dunn, Terry E.
    Feuerstein, Steven
    Jacobs, David M.
    PHARMACOTHERAPY, 2019, 39 (04): : 443 - 453
  • [10] Effects of Proton Pump Inhibitors Intake During Chemoradiotherapy for Rectal Cancer: a Retrospective Cohort Study
    Bridoux, Marie
    Le Deley, Marie-Cecile
    Bertrand, Nicolas
    Simon, Nicolas
    Sylla, Dienabou
    Mirabel, Xavier
    Turpin, Anthony
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (02) : 545 - 553